Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II oral panobinostat in relapsed or refractory diffuse large B-cell lymphoma
2011-000175-13Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panobinostat in diffuse large B-cell lymphoma (DLBCL) and mature B-cell lymphoma, sponsored by Fondazione Italiana Linfomi. Primary endpoint: Overall response. Started May 2011; status: completed.
02
Drugs
panobinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)mature B-cell lymphoma
Beyond the preview
Go deeper on 2011-000175-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000175-13.